Next-generation sequencing (NGS) in relapsed/refractory triple-negative breast cancer (TNBC) in Israel.
Noa Ben-Baruch(Kaplan Medical Center), Jeffrey S. Ross(SUNY Upstate Medical University), Victoria Neiman(Rabin Medical Center), Lior Soussan‐Gutman(Teva Pharmaceuticals (Israel)), Tamar Safra, Moshe Inbar(Assuta Medical Center), Phil Stephens(Wellcome Sanger Institute), Karen Drumea(Rambam Health Care Campus), Samih Yousef(Emek Medical Center), Rony Weitzen(Sheba Medical Center), Kai Wang(Michigan United), Bella Nisenbaum(Meir Medical Center), Tamar Peretz‐Yablonski(Hadassah Medical Center), Vincent A. Miller(Universidad San Carlos), Neil Friedman(Cleveland Clinic), Addie Dvir(Teva Pharmaceuticals (Israel)), Georgeta Fried(Roche (Switzerland))
Cited by 1
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
The MicroRNA Spectrum in 12 Body Fluids
|Clinical Chemistry|2010|2.8k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
|Molecular Cancer Therapeutics|2017|2.4k